.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Transdermal drug delivery is evolving rapidly, yet traditional dissolving microneedles (DMNs) face significant clinical hurdles. The diffusion of drugs into the backing layer during production often reduces dose accuracy. Moreover, many existing systems suffer from slow dissolution rates and mechanical fragility. To address these barriers, researchers developed Lyophilized Microneedle Systems using Biocompatible Glue (LMS-BG). This modular platform ensures efficient drug localization and rapid onset, specifically designed for clinical viability.
The LMS-BG architecture consists of a drug-loaded tip coupled with a prefabricated backing through a biodegradable, ethanol-based glue. This biocompatible glue (BC glue) provides two vital functions. First, it ensures that the drug remains confined to the microneedle tip rather than migrating into the backing material. Second, the glue partially interpenetrates the porous, lyophilized structure to reinforce the needles mechanically. Consequently, these needles can penetrate the skin effectively despite their amorphous microstructure. Furthermore, this reinforcement prevents the typical fragility associated with porous materials.
Using lidocaine hydrochloride (LiH) as a model drug, this system demonstrated remarkable performance in laboratory and animal tests. In comparative evaluations, the LMS-BG achieved an 11-fold faster dissolution rate than conventional microneedle systems. Additionally, the platform retained over 96% of the drug within the tip. Within just two minutes of application, the transdermal delivery efficiency exceeded 90%. In vivo studies in rat models also confirmed that LMS-BG provides superior local anesthetic effects compared to commercial gels. Ultimately, the system provides excellent biocompatibility while maintaining high mechanical strength for successful skin insertion.
The versatility of the LMS-BG fabrication method is one of its most promising features. Researchers successfully extended the technology to platforms using soluble polymers, hydrogels, and even PLGA nanoparticles. This modularity suggests that the system can be scaled for various therapeutic agents beyond local anesthetics. In addition, the prefabricated backing approach allows for mass production without compromising the stability of sensitive drugs. This study addresses the primary translational barriers of traditional microneedles, offering a robust path for modern medical practice.
The LMS-BG system significantly accelerates drug dissolution, reaching an 11-fold faster rate than conventional dissolving microneedles. It also ensures that nearly all the medication stays in the needle tip for maximum delivery efficiency.
The biocompatible glue anchors the drug-loaded tip to the backing and reinforces the porous structure. This design prevents drug waste and provides the mechanical strength needed to pierce the skin barrier effectively.
The system is highly efficient, delivering over 90% of its drug payload within just two minutes of application. This makes it significantly faster than standard anesthetic creams or traditional microneedle patches.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Kim ST et al. Biocompatible Glue-Enabled Drug Localization and Mechanical Reinforcement of Lyophilized Microneedle Systems. Small. 2026 Feb 07. doi: 10.1002/smll.202512379. PMID: 41653461.
Zhu J et al. Enhanced Transdermal Delivery of Lidocaine Hydrochloride via Dissolvable Microneedles (LH-DMNs) for Rapid Local Anesthesia. Pharmaceutics. 2025 Aug 21;17(8):1245.
Zhang X et al. Lidocaine-Loaded Hyaluronic Acid Adhesive Microneedle Patch for Oral Mucosal Topical Anesthesia. MDPI Pharmaceutics. 2022 Mar 22;14(4):689.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The LMS-BG platform utilizes biocompatible glue and lyophilization to enhance microneedle drug localization, mechanical strength, and dissolution rates....
7 months ago
A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
